HemoSonics
HemoSonics is a medical device company that develops the Quantra Hemostasis System, a point-of-care viscoelastic testing platform using proprietary SEER Sonorheometry ultrasound technology to characterize whole-blood coagulation for acute-care hospital departments in the US and Europe.
- Company typePrivate
- Founded2004
- HeadquartersCharlottesville, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What HemoSonics does
HemoSonics is a privately held medical device company that develops and commercializes the Quantra Hemostasis System, a point-of-care viscoelastic testing (VET) platform for whole-blood coagulation analysis in acute-care hospital settings. The company is incorporated as HemoSonics, LLC, headquartered in Durham, North Carolina, with a European sales operation based in Asnières-sur-Seine, France. Its clinical footprint spans obstetric, cardiac surgery, trauma, liver transplantation, and major orthopedic surgery departments across US and European hospitals, with the September 2025 FDA 510(k) clearance for peripartum obstetric procedures establishing the Quantra System as the first and only FDA-cleared VET platform for that indication.
The core product architecture rests on a proprietary ultrasound-based technology called SEER (Sonic Estimation of Elasticity via Resonance) Sonorheometry, protected by at least 11 granted US patents. The system consists of a capital equipment analyzer (HS-002) paired with two disposable cartridge types — the QPlus Cartridge for cardiovascular and major orthopedic surgery, and the QStat Cartridge for trauma, liver transplantation, and peripartum obstetrics. Cartridge parameters include Clot Time, Clot Stiffness, Fibrinogen Contribution to Clot Stiffness, Platelet Contribution to Clot Stiffness, and Clot Stability to Lysis, with results available in approximately 5 minutes initially and 12.5 minutes complete. The platform integrates with at least seven major hospital middleware systems (Abbott RALS/Aegis, Siemens POCcelerator/UniPOC, Roche cobas, Radiometer AQURE, Data Innovations, Telcor) and participates in Stago's Qualiris external quality assessment program.
HemoSonics operates a razor-and-blade revenue model combining one-time capital equipment sales with recurring cartridge and quality control consumable revenue, supplemented by the Quantra Desktop Remote Viewer (QDRV) software (perpetual license, no annual fee) and comprehensive professional services. Go-to-market is direct enterprise field sales to hospitals in the US and Europe, supported by clinical evidence marketing (56+ publications, 67+ abstracts since 2020) and society partnerships including the Society for Maternal-Fetal Medicine. Pricing is not publicly disclosed; the company has raised approximately $17.8M cumulatively across disclosed funding events (largest a 2017 $15M round) and received a 2024 NIH RADx Tech grant of $525,000 for the obstetric application.
HemoSonics firmographics
Firmographics- Name
- HemoSonics
- Legal name
- HemoSonics, LLC
- Website
- https://hemosonics.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- HemoSonics is a medical device company that develops the Quantra Hemostasis System, a point-of-care viscoelastic testing platform using proprietary SEER Sonorheometry ultrasound technology to characterize whole-blood coagulation for acute-care hospital departments in the US and Europe.
- Ownership category
- akta.pro rank
HemoSonics industry classification
Industry- Product category
- Hemostasis Diagnostics
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hematology & Coagulation Diagnostics (HLAHAAAB)
- akta.pro secondary industries
- Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer) (HLAHAOAC)
Keywords
Where HemoSonics is headquartered
LocationHeadquarters
- HQ city
- Charlottesville
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
HemoSonics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Quantra Hemostasis Analyzer Hardware Sales: HemoSonics sells the Quantra Hemostasis Analyzer (part number HS-002) as capital equipment to hospitals and healthcare facilities. The analyzer is the hardware platform on which QPlus and QStat cartridges are run.
- QPlus and QStat Cartridge Sales: The company sells disposable cartridges (QPlus and QStat) in kits of 10. These are recurring consumable revenue streams as cartridges are used per test. Both cartridge types can be stored at room temperature. Pricing is provided through sales representatives.
- Quality Control Kit Sales: External biological Quality Control materials (Level 1 and Level 2) are sold separately for both QPlus and QStat cartridges. These support laboratory-defined requirements and IQCP compliance, representing a recurring consumable revenue stream.
- Quantra Desktop Remote Viewer (QDRV) Software: QDRV software (part number KT-0039) is sold as a PC application. Each purchase includes one year of free updates. There is no annual license fee. Software enables remote viewing of real-time and historical results from networked Quantra analyzers.
- Professional Services and Implementation Support: HemoSonics provides comprehensive installation, validation, training, algorithm development, clinical affairs support, professional education, and ongoing business review services to healthcare facilities implementing the Quantra System. These support services are offered as part of the partnership approach to drive adoption and long-term value.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Quantra Hemostasis Analyzer (HS-002) — Capital Equipment |
| Unit Pricing | Pay-as-you-go | QPlus Cartridge Kit of 10 (KT-0004) and QStat Cartridge Kit of 10 (KT-0020) |
| Unit Pricing | Pay-as-you-go | Quantra Quality Controls — Level 1 and Level 2 for QPlus and QStat |
| One time/ perpetual license | Multi-year contract | Quantra Desktop Remote Viewer (QDRV) Software (KT-0039) |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
HemoSonics product offering
Product offeringCore offering
HemoSonics develops and sells the Quantra Hemostasis System, a cartridge-based point-of-care viscoelastic testing (VET) platform that uses proprietary SEER (Sonic Estimation of Elasticity via Resonance) Sonorheometry ultrasound technology to measure clot time, clot stiffness, fibrinogen contribution, and platelet contribution in whole blood. The system consists of the Quantra Hemostasis Analyzer hardware paired with QPlus Cartridges (cardiac and major orthopedic surgery) and QStat Cartridges (trauma, liver transplantation, and peripartum obstetric procedures), and is sold to acute-care hospitals in the USA and Europe.
Product overview
HemoSonics offers the Quantra Hemostasis System, a cartridge-based whole blood viscoelastic testing (VET) platform for point-of-care and laboratory coagulation analysis. The system consists of the Quantra Hemostasis Analyzer as the core hardware platform, paired with two distinct cartridge types: the QPlus Cartridge for cardiovascular and major orthopedic surgeries, and the QStat Cartridge for trauma, liver transplantation, and peripartum obstetric procedures. Supporting products include Quantra Quality Control Kits for quality assurance, the Quantra Desktop Remote Viewer (QDRV) software for facility-wide result monitoring, and the Qualiris EQA Proficiency Program for external quality assessment. Accessories include the Quantra Printer and Cleaning Cartridge.
Differentiator
Problem solved
Functional benefit
Brands
- Quantra Hemostasis System: Point-of-care viscoelastic testing (VET) platform for whole blood hemostasis analysis, including the Quantra Analyzer and QPlus/QStat cartridges.
- QPlus Cartridge
- QStat Cartridge
- SEER Sonorheometry
- Qualiris EQA Proficiency Testing Program
Products and services
- Quantra Hemostasis Analyzer The main whole blood hemostasis analyzer device (part number HS-002) that uses proprietary SEER Sonorheometry ultrasound technology to measure viscoelastic properties of blood for point-of-care and laboratory coagulation testing. Sold as capital equipment to hospitals and healthcare facilities.
- QPlus Cartridge A disposable cartridge (part number KT-0004, kits of 10) for the Quantra System indicated for cardiovascular and major orthopedic surgeries, providing Clot Time, Clot Time with Heparinase, Clot Stiffness, Fibrinogen Contribution to Clot Stiffness (FCS), and Platelet Contribution to Clot Stiffness (PCS) measurements.
- QStat Cartridge A disposable cartridge (part number KT-0020, kits of 10) for the Quantra System indicated for trauma, liver transplantation, and peripartum obstetric procedures, providing Clot Time, Clot Stiffness, and Clot Stability to Lysis measurements including TXA comparison.
- Quantra Quality Control Kits External biological quality control materials (Level 1 and Level 2) supplied in kits of 4 for the Quantra System. Supports the development of Individual Quality Control Plans (IQCP) and verifies performance of cartridge parameters for QPlus and QStat.
- Quantra Desktop Remote Viewer (QDRV) PC application software (part number KT-0039) that allows remote viewing of real-time screens from any networked Quantra analyzer, enabling viewing of dials, trends, curves, and historical results across facility-wide Windows workstations. Sold as a one-time perpetual license with one year of free updates and no annual license fee.
- Qualiris EQA Proficiency Program External Quality Assessment (EQA) proficiency testing program for the Quantra System with QPlus and QStat Cartridges, offered in partnership with Stago. Provides peer-to-peer comparison and comprehensive statistical analysis across global laboratories with Spring and Fall test materials in one kit.
- Quantra Printer Accessory for the Quantra Hemostasis Analyzer that enables printing of numeric results.
- Quantra Cleaning Cartridge Accessory for use with the Quantra Hemostasis Analyzer intended for periodic cleaning of the system.
Quantifiable outcome
- Reduced unnecessary blood product usage — VET has been demonstrated in clinical studies to reduce transfusion requirements in cardiac surgery and trauma patients.
- +5 more outcomes
Companies that use HemoSonics
Customer profileSegments4 records
Ideal customer profiles2 records
HemoSonics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
Feature8 records
HemoSonics partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and supporting.
- Stago (sthEMe Qualiris)coreStago's sthemE Qualiris is a trusted External Quality Assessment (EQA) Proficiency Testing program supporting hemostasis and thrombosis testing worldwide. The program provides Spring and Fall test materials in one kit for peer-to-peer comparison across a global participant group for both QPlus and QStat cartridges. Qualiris enables laboratories to confidently assess proficiency test results through detailed comparisons among a diverse global peer group.
- Abbott (RALS Data Management, Aegis POC)coreAbbott's RALS Data Management System and Aegis POC middleware integrate with the Quantra System to enable scalable POC device deployment, centralized QC and user management, EMR/EHR/LIS data transfer, and compliance with POC connectivity standards (CLSI POCT01-A2, CLSI LIS02-A2).
- Siemens Healthineers (POCcelerator, UniPOC)coreSiemens Healthineers POCcelerator and UniPOC middleware solutions provide integrated connectivity for the Quantra System, enabling hospitals to centralize POC device data, manage operator certifications, monitor QC results, and send patient test results to EMR/EHR/LIS systems.
- Roche (COBAS IT 1000 / Infinity)supportingRoche's COBAS IT 1000 and Infinity POC middleware platforms integrate with the Quantra System to enable connectivity to EMR/EHR/LIS systems, supporting scalable POC deployment across hospital institutions.
- Radiometer (AQURE)supportingRadiometer's AQURE middleware platform provides connectivity for the Quantra System, enabling centralized POC device data management, QC monitoring, and integration with hospital information systems.
- Data Innovations (Instrument Manager)supportingData Innovations Instrument Manager provides middleware connectivity for the Quantra System, enabling integration with hospital laboratory and POC IT infrastructure for data management and reporting.
- Telcor (QML)supportingTelcor QML middleware integrates with the Quantra System to support POC connectivity, enabling transfers of results to EMR/EHR/LIS, centralized QC management, and operator certification tracking.
- Society for Maternal-Fetal Medicine (SMFM)supportingHemoSonics joined SMFM as an Ambassador during High-Risk Pregnancy Awareness Week (June 1-8, 2026) to support clinicians and organizations dedicated to improving outcomes in high-risk pregnancy care through greater awareness and collaboration.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
HemoSonics competitors and assessment
Company assessmentBroad incumbents
- Siemens Healthineers: Siemens Healthineers is a broad incumbent in hospital hemostasis and POC diagnostics with POCcelerator and UniPOC middleware that integrate with Quantra. Siemens offers its own coagulation analyzers and competes for the same hospital blood-gas / coagulation testing budgets.
- Abbott: Abbott is a broad incumbent in hospital diagnostics whose RALS and Aegis POC middleware platforms integrate with the Quantra System. Abbott also offers its own coagulation/POCT portfolio (iSTAT and central lab analyzers), making it an adjacent competitor as well as a connectivity partner.
- Radiometer: Radiometer (a Danaher company) provides the AQURE middleware platform used to integrate Quantra analyzers and is itself a global incumbent in blood gas and acute-care diagnostics, including adjacent POCT menus that compete for hospital POC budgets.
- Roche Diagnostics: Roche provides cobas IT 1000 / Infinity middleware that integrates with Quantra and is a broad incumbent in central laboratory and POC diagnostics, including coagulation testing — comparable as both an integration partner and a partial competitive overlap.
Emerging players
- Stago: Stago is a global hemostasis diagnostics specialist and HemoSonics' strategic partner for the Qualiris EQA program; Stago also distributes related hemostasis instrumentation and reagents (e.g., qLabs FIB) and is therefore both a partner and a partial competitor in coagulation diagnostics.
Others
- Data Innovations: Data Innovations provides Instrument Manager middleware that integrates with the Quantra System for laboratory and POC data management — an ecosystem enabler rather than a direct competitor in hemostasis testing.
- Telcor: Telcor provides QML middleware used to integrate Quantra analyzers with EMR/EHR/LIS systems — an enabling infrastructure vendor comparable to HemoSonics' integration strategy rather than a direct diagnostic competitor.
Direct peers
- Haemonetics: Haemonetics manufactures the TEG (Thromboelastography) hemostasis analyzer portfolio — the most direct global VET competitor to the Quantra System across cardiac surgery, trauma, and transplant. HemoSonics competes head-to-head against TEG for the same hospital point-of-care hemostasis budget.
- Werfen (ROTEM / Instrumentation Laboratory): Werfen's ROTEM viscoelastic testing system (via Instrumentation Laboratory) is the second global VET incumbent alongside TEG. ROTEM directly competes with Quantra in the same perioperative and trauma indications and shares similar cartridge-style consumable economics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
HemoSonics social profiles
Digital presenceHemoSonics compliance and trust
Trust signalCompliance2 records
HemoSonics financial estimates
Financial estimateRevenue estimate
Valuation estimate
HemoSonics leadership team
Management profileNumber of profiles
Profiles6 records
HemoSonics funding detail
Funding detailFunding overview
Funding rounds4 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HemoSonics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HemoSonics
What does HemoSonics do?
HemoSonics develops and sells the Quantra Hemostasis System, a cartridge-based point-of-care viscoelastic testing (VET) platform that uses proprietary SEER (Sonic Estimation of Elasticity via Resonance) Sonorheometry ultrasound technology to measure clot time, clot stiffness, fibrinogen contribution, and platelet contribution in whole blood. The system consists of the Quantra Hemostasis Analyzer hardware paired with QPlus Cartridges (cardiac and major orthopedic surgery) and QStat Cartridges (trauma, liver transplantation, and peripartum obstetric procedures), and is sold to acute-care hospitals in the USA and Europe.
Is HemoSonics a public or private company?
HemoSonics is a private company. It is classified as venture growth investor backed and is currently operating.
When was HemoSonics founded?
HemoSonics was founded in 2004. It employs 1 to 10 people.
Where is HemoSonics based?
HemoSonics is headquartered in Charlottesville, United States, in the North America region.
How does HemoSonics make money?
Five revenue lines are on record. Quantra Hemostasis Analyzer Hardware Sales are the primary driver. The others are QPlus and QStat Cartridge Sales, quality Control Kit Sales, quantra Desktop Remote Viewer (QDRV) Software and professional Services and Implementation Support.
Who are HemoSonics's main competitors?
Broad incumbents on record are Siemens Healthineers, Abbott, Radiometer and Roche Diagnostics. Stago is listed as an emerging player. Others are Data Innovations and Telcor. Direct peers are Haemonetics and Werfen (ROTEM / Instrumentation Laboratory).
Does HemoSonics have an API?
No public API is recorded for HemoSonics.
What industry is HemoSonics in?
HemoSonics's product category is Hemostasis Diagnostics. Its primary akta.pro industry code is HLAHAAAB, Hematology & Coagulation Diagnostics, with a secondary code of HLAAALAH, Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing). Its NAICS code is 334510 and its SIC code is 3826.